Tryptamine

Tryptamine

SCHEMBL8714244

NCCc1c[nH]c2ccccc12.NCCc1c[nH]c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 9/20 1.00
▸ HTR2C P28335 4/20 1.00
▸ HTR6 P50406 4/20 1.00
▸ CYP3A4 P08684 3/20 1.00
▸ HTR1D P28221 3/20 1.00
▸ MPO P05164 2/20 1.00
▸ CYP1A2 P05177 2/20 1.00
▸ CYP2D6 P10635 2/20 1.00
▸ HTR1B P28222 2/20 1.00
▸ HTR7 P34969 2/20 1.00
▸ TAAR1 Q96RJ0 2/20 1.00
▸ CYP2A6 P11509 1/20 1.00
▸ NFKB1 P19838 1/20 1.00
▸ CTSK P43235 1/20 1.00
▸ CYP2A13 Q16696 1/20 1.00
▸ PMP22 Q01453 1/20 0.96
▸ MEN1 O00255 1/20 0.64
▸ MAPT P10636 1/20 0.64
▸ AHR P35869 1/20 0.64
▸ KMT2A Q03164 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tryptamine SCHEMBL26725 1.00 HTR2A (1.00) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL29373222 1.00 HTR2A (1.00) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL28679044 0.98 HTR2A (0.96) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL274183 0.98 PMP22 (1.00) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL28686775 0.98 PMP22 (1.00) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL10874156 0.98 HTR2A (0.96) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL599675 0.98 HTR2A (0.96) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL22127053 0.98 HTR2A (0.96) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL4936407 0.98 HTR2A (0.96) HTR2AHTR2CHTR6CYP3A4HTR1D
Tryptamine SCHEMBL9472063 0.98 HTR2A (0.96) HTR2AHTR2CHTR6CYP3A4HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024058984-A2 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES MarvelBiome, Inc. (US) 2024-03-21 — — WO disclosed
US-20240076711-A1 IDENTIFICATION OF MITOCHONDRIA-ENRICHED CELLS MINOVIA THERAPEUTICS LTD. (IL) 2024-03-07 — — US disclosed
CN-115867533-A Tryptamine prodrugs 加拿大瑞安神经科学公司 2023-03-28 — — CN disclosed
US-5814520-A ISOLATED AND PURIFIED DNA FRAGMENT COMPRISING A SEQUENCE ENCODING A PLANT DECARBOXYLASE NATIONAL RESEARCH COUNCIL CANADA (CA) 1998-09-29 — — US disclosed
Send feedback